Kavsur Refik, Hupp Hannah, Sugiura Atsushi, Öztürk Can, Weber Marcel, Nickenig Georg, Tiyerili Vedat, Becher Marc Ulrich
Department of Internal Medicine II, University Hospital Bonn, Bonn, Germany.
Department of Internal Medicine II, University Hospital Bonn, Bonn, Germany.
Int J Cardiol. 2020 Nov 1;318:32-38. doi: 10.1016/j.ijcard.2020.06.031. Epub 2020 Jun 27.
TTVR represents a minimal invasive alternative for patients with tricuspid regurgitation (TR). PCWP is a haemodynamic parameter indicating pulmonary hypertension due to left-sided heart failure.
We evaluated pulmonary capillary wedge pressure (PCWP) as prognostic outcome parameter in patients undergoing transcatheter tricuspid valve repair (TTVR). A total of 60 patients who underwent right heart catheterization prior to TTVR were included. Patient population was categorized into a low and high PCWP group according to the median PCWP of 16 mmHg.
TTVR included transcatheter tricuspid annuloplasty (13 patients) and edge-to-edge repair [37 patients for isolated TR; 10 patients for combined TR and mitral regurgitation]. Kaplan-Meier analysis and log-rank test revealed reduced 6-months event-free survival for patients with high PCWP (>16 mmHg) in comparison to those with low PCWP (≤16 mmHg) (p = 0.009). High PCWP was associated with increased occurrence of the composite endpoint of death and cardiac readmission (HR 4.67, 1.32-16.55). Moreover, adjusted with other predictive variables within the univariate analysis (left ventricular ejection fraction, history of smoking, tricuspid annular plane systolic excursion), PCWP remained an endpoint predictor (HR 1.11, 1.003-1.24). Best predicting value was evaluated for the cut-off >16 mmHg (AUC 0.700, 0.552-0.848). Patients with a high PCWP tended to have less TR recurrence (p = 0,059) and lower NYHA class (p = 0.062) after one month of follow-up.
Here we demonstrate that PCWP is a predictive outcome parameter in TTVR patients. Patients with a PCWP ≤16 mmHg had a favourable outcome with lower mortality and morbidity gaining more benefit of TTVR.
经导管三尖瓣修复术(TTVR)是三尖瓣反流(TR)患者的一种微创替代治疗方法。肺毛细血管楔压(PCWP)是一项血流动力学参数,可提示左心衰竭所致的肺动脉高压。
我们将肺毛细血管楔压(PCWP)作为接受经导管三尖瓣修复术(TTVR)患者的预后结局参数进行评估。总共纳入了60例在TTVR术前接受右心导管检查的患者。根据PCWP中位数16 mmHg将患者人群分为低PCWP组和高PCWP组。
TTVR包括经导管三尖瓣环成形术(13例患者)和缘对缘修复术[单纯TR 37例患者;TR合并二尖瓣反流10例患者]。Kaplan-Meier分析和对数秩检验显示,与低PCWP(≤16 mmHg)患者相比,高PCWP(>16 mmHg)患者的6个月无事件生存率降低(p = 0.009)。高PCWP与死亡和心脏再入院复合终点事件的发生率增加相关(风险比4.67,1.32 - 16.55)。此外,在单因素分析中对其他预测变量(左心室射血分数、吸烟史、三尖瓣环平面收缩期位移)进行校正后,PCWP仍然是终点预测指标(风险比1.11,1.003 - 1.24)。对>16 mmHg的截断值评估最佳预测价值(曲线下面积0.700,0.552 - 0.848)。随访1个月后,高PCWP患者的TR复发倾向较低(p = 0.059),纽约心脏协会(NYHA)心功能分级较低(p = 0.062)。
在此我们证明,PCWP是TTVR患者的一项预测结局参数。PCWP≤16 mmHg的患者预后良好,死亡率和发病率较低,从TTVR中获益更多。